Pfizer and BioNTech are working to develop an mRNA-based shingles vaccine following the success of the COVID-19 shot. This latest collaboration will mark the third time the pharmaceutical companies have worked together on a vaccine.
Fiserv's Shannon Watkins talks about driving change at the intersection of commerce, culture, and community- all while tackling small business failure rates.
